← brief for 2026-09-01 · Regeneration & devices

Advanced nanocatalytic medicine for genitourinary diseases: Reactive oxygen modulation, precision therapeutics, and clinical translation.

Key takeaways

A review of tiny engineered particles, called nanocatalysts, being designed to treat kidney and urinary diseases. They are built to react to conditions found in damaged tissue, such as low oxygen and high levels of harmful oxygen molecules, and to act only there. Almost all of this work is still in cells and animals. The article summarizes the field and reports no results in people.

Who did this work

Li H · Geng Y · Wang L · Jiang S · Du M · Sun Y · Li L · Zhu X

Source

Article · PubMed, organoids & devices · 2026 Aug 14
https://pubmed.ncbi.nlm.nih.gov/42677133/